Cytokinetics, Inc. (CYTK)
63.28
-1.36
(-2.10%)
USD |
NASDAQ |
Jan 13, 16:00
63.28
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Research and Development Expense (Quarterly): 96.55M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 2.433B |
| Molina Healthcare, Inc. | -- |
| Jasper Therapeutics, Inc. | 14.39M |
| Fortrea Holdings, Inc. | -- |
| Lifecore Biomedical, Inc. | 1.963M |